ACRS — Aclaris Therapeutics, Inc. | XLV Holdings | StockAdder

(ACRS)

Aclaris Therapeutics, Inc.

Live chart and latest ACRS stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

ACRS News

Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) high institutional ownership speaks for itself as stock continues to impress, up 72% over last week

Jan 26, 2026 Yahoo Finance

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Feb 26, 2026 Stock Titan

ACRS SEC Filings - Aclaris Therapeutics Inc 10-K, 10-Q, 8-K Forms

Apr 2, 2026 TradingView — Track All Markets

Aclaris Therapeutics sells 12.7M shares for $39.8M under ATM offering

Mar 10, 2026 Moomoo

There's Reason For Concern Over Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Massive 41% Price Jump

Jan 21, 2026 TipRanks

Aclaris Therapeutics Raises Capital via Institutional Stock Sale

Mar 10, 2026 Quiver Quantitative

Aclaris Therapeutics Added to Nasdaq Biotechnology Index Effective December 19, 2025

Dec 19, 2025 simplywall.st

There's Reason For Concern Over Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Massive 25% Price Jump

Feb 3, 2026 Yahoo Finance

Acadian Increases Stake in Aclaris Therapeutics, Inc. (ACRS) as Phase 2a Data Gains Spotlight

Sep 21, 2025 Stock Titan

New eczema trial results from Aclaris will debut at dermatology meeting

Mar 20, 2026 Yahoo Finance

Earnings Beat: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 10, 2025 Stock Titan

Experimental eczema pill cut disease severity 77% in 12-week trial

Mar 27, 2026 Yahoo Finance

What Makes Aclaris Therapeutics (ACRS) a Strong Momentum Stock: Buy Now?

Oct 21, 2025 Stock Titan

Vanguard (ACRS) Amends Schedule 13G; Reports 0 Shares After Realignment

Mar 26, 2026 Yahoo Finance

Aclaris Therapeutics (NASDAQ:ACRS) adds US$40m to market cap in the past 7 days, though investors from three years ago are still down 83%